Carboplatin and Paclitaxel as Therapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

CME test	Downloadable PDF	PowerPoint slides	CME Information and Faculty Disclosures
Read Dr Love's original email (from July 30, 2010)			Subscribe to Dr Love's email alerts

Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with F Anthony Greco, MD (6/15/10), Roy S Herbst, MD, PhD (6/23/10) and Corey J Langer, MD (7/2/10)

 

Quoix EA et al. Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC). Proc ASCO 2010;Abstract 7509.

Go to previous Journal Club